A single 0.5 mg dose of Xanax (alprazolam) clears from the bloodstream of a healthy adult in roughly two to three days, though traces remain detectable in urine for up to a week and in hair for months. The timeline depends heavily on your body, your health, and which type of test is being used. The drug’s average half-life in healthy people hovers around 11 hours, but that number nearly doubles for older adults, people with liver disease, or those carrying extra body weight, which means “how long” has a different answer for different people.
What Happens to Alprazolam After You Take It
Alprazolam is broken down primarily in the liver by an enzyme called CYP3A4. That process produces two main byproducts: one called 4-hydroxy alprazolam, which has little pharmacological punch, and another called alpha-hydroxy alprazolam, which is actually more active than many people realize.1PubMed. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite Both metabolites eventually get processed further and excreted, mostly through the kidneys. This is why urine tests pick up not just the parent drug but also its breakdown products.
The half-life of a drug is the time it takes for your body to eliminate half of what you ingested. In healthy young adults, alprazolam’s half-life averages about 11.4 hours.2PubMed. Alprazolam pharmacokinetics in alcoholic liver disease After roughly five half-lives, the drug’s concentration has dropped to a negligible amount. For someone with an 11-hour half-life, that means alprazolam is functionally out of the blood in about 55 to 60 hours, or a little over two days. But “functionally gone” from the bloodstream is not the same thing as undetectable on every type of drug test.
Detection Windows by Test Type
Different biological samples hold onto drugs and their metabolites for very different lengths of time. The test your employer, doctor, or legal authority uses determines how far back the window reaches.
Blood and Saliva
Blood tests reflect what is circulating in your system right now. Because alprazolam’s half-life is relatively short, blood concentrations drop below detectable thresholds within one to three days for most healthy adults taking a single 0.5 mg dose. Saliva follows a similar trajectory. A study of patients admitted for detoxification found that the maximum detection time for alprazolam in oral fluid was 2.5 days, and that was in people who had been taking high or repeated doses, not a one-time low dose.3Therapeutic Drug Monitoring. Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake Sensitive analytical methods with very low detection thresholds can confirm recent benzodiazepine intake from oral fluid, but even these have limits measured in days, not weeks.4Therapeutic Drug Monitoring. Detection of 4 Benzodiazepines in Oral Fluid as Biomarker for Presence in Blood
Urine
Urine testing is the most common method used in workplace and clinical drug screens. Alprazolam and its metabolites are generally detectable in urine for about one to seven days after a single dose, though the exact window depends on the sensitivity of the assay, your metabolism, and how much you took. A 0.5 mg dose sits on the lower end of that range for most people, and in healthy adults the drug and its metabolites tend to clear urine within a few days. One complication with standard immunoassay urine panels is that they are designed to detect a broad class of benzodiazepines, and alprazolam has sometimes been tricky for these screens. Different immunoassay platforms vary in their ability to detect alprazolam; some have cross-reactivity that is only equivalent to or slightly better than the detection of other benzodiazepines, while others show enhanced sensitivity at certain concentration ranges.5Journal of Analytical Toxicology. Immunoassay Detection of Nordiazepam, Triazolam, Lorazepam, and Alprazolam in Blood This means that a low dose like 0.5 mg is more prone to being missed by a basic urine screen than a higher dose would be, particularly if the test is administered a few days after ingestion.
Hair
Hair testing operates on a completely different timescale. Drugs get incorporated into the hair shaft as it grows, and because hair grows slowly and the compounds remain stable once embedded, the detection window stretches to roughly 90 days or more.6PubMed Central. Hair testing for investigating intake and use history of hypnotics in the forensic field Hair testing is used less frequently in routine screening and more in forensic or legal settings where a longer history of use matters. A single 0.5 mg dose may or may not deposit enough drug into the hair to be reliably detected, since the amount incorporated depends on the drug’s properties, hair color, and the sensitivity of the testing method. Chronic or repeated use is far more likely to show up in hair than a one-time dose.
Factors That Slow Down Elimination
That 11-hour half-life number comes from studies of healthy young adults, and many people do not fit neatly into that category. Several well-studied factors can roughly double the time alprazolam lingers in your body.
Age
Elderly adults clear alprazolam more slowly. A study of older men found that oral clearance values were substantially lower than those seen in younger adults, and half-lives exceeded 21 hours.7PubMed. Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing That means five half-lives could stretch well past four days. The slowdown is largely because liver enzyme activity declines with age, and kidney function often does too. If you are over 65, the drug stays in your system meaningfully longer than published averages suggest.
Body Weight and Composition
Alprazolam is lipophilic, meaning it dissolves readily in fat tissue. In people with obesity, the drug distributes into a much larger volume of body fat, and that reservoir releases it back into the bloodstream slowly. Research comparing obese and normal-weight subjects found that the volume of distribution was substantially larger in obese individuals, and the elimination half-life doubled from about 11 hours to 22 hours.8PubMed. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam The drug was not being broken down any slower; it was simply taking longer to leave because there was more tissue holding onto it.
Liver Health
Since CYP3A4 in the liver does the heavy lifting of metabolizing alprazolam, liver disease predictably slows the whole process. Patients with alcoholic liver disease had an average half-life of about 20 hours, compared to roughly 11 hours in people with healthy livers, and their clearance was about half as fast.2PubMed. Alprazolam pharmacokinetics in alcoholic liver disease Even moderate liver impairment can shift elimination times enough to matter, especially if you are taking additional medications that also depend on the same liver enzymes for processing.
Genetics
Not everyone has the same version of the enzymes that process alprazolam. The CYP3A5 gene, which helps supplement CYP3A4 activity, comes in different variants. People who carry two copies of the less-active CYP3A5*3 variant clear alprazolam about 30% more slowly than those with two copies of the fully active CYP3A5*1 variant.9PubMed. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects Most people never have their CYP3A5 genotype tested, so this is an invisible source of variability. If you feel like the drug affects you more strongly or for longer than others report, genetic enzyme differences may be part of the explanation.
Does Smoking Make a Difference?
Cigarette smoking speeds up the activity of certain liver enzymes, and there is evidence that smokers clear several benzodiazepines faster than non-smokers.10PubMed. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective For alprazolam specifically, the picture is less dramatic. A study comparing smokers and non-smokers found that smokers had about 24% faster clearance and that non-smokers had a roughly 49% longer elimination half-life, but these differences did not reach statistical significance.11PubMed. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men In practical terms, smoking may shorten the drug’s stay in your body somewhat, but the effect is modest compared to the impact of age, weight, or liver function. It is not something you should count on to speed up clearance before a drug test.
Does the 0.5 mg Dose Size Matter?
People often wonder whether a smaller dose leaves the system faster than a larger one. In pharmacokinetic terms, the half-life of alprazolam does not change based on dose. Whether you take 0.25 mg or 2 mg, the body eliminates roughly the same fraction of drug per unit of time. What changes is the starting concentration: a lower dose means you begin with less drug in your blood, so the concentration drops below detectable thresholds sooner. For a 0.5 mg dose, peak blood concentrations are relatively low to begin with, and the drug falls below most detection limits faster than it would after a 1 mg or 2 mg dose. This is especially relevant for urine and saliva tests, where the total amount of metabolite excreted determines whether the result clears the assay’s cutoff.
If you take alprazolam repeatedly rather than as a single dose, the math shifts. With daily dosing, the drug accumulates because each new dose arrives before the previous one has fully cleared. Steady-state concentrations build up, and once you stop, it takes longer for everything to wash out. The detection windows discussed earlier apply most cleanly to single or occasional doses. Someone who has been taking 0.5 mg daily for weeks will test positive longer than someone who took one pill once.
Extended-Release Formulations
Xanax comes in both immediate-release and extended-release (Xanax XR) forms. The extended-release version is designed to release the drug more slowly, producing a flatter, more sustained blood concentration curve rather than a sharp peak and drop. A pharmacokinetic study of Xanax XR examined blood levels for 48 hours after a single dose in healthy volunteers.12PubMed Central. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers Because the drug is absorbed more gradually, peak concentration is lower but the tail end of the curve stretches out further. If you are taking the XR formulation, expect the drug to remain detectable for somewhat longer than the immediate-release version at the same total dose. Most people prescribed 0.5 mg are taking the immediate-release form, but it is worth knowing the distinction if your prescription is for the extended-release tablet.
Why Standard Drug Screens Sometimes Miss Alprazolam
An unexpected wrinkle that trips people up on both sides of the equation: standard immunoassay drug panels are calibrated to detect benzodiazepines broadly, but they rely on cross-reactivity with the specific metabolites each drug produces. Alprazolam’s metabolites do not always cross-react strongly with every immunoassay platform.5Journal of Analytical Toxicology. Immunoassay Detection of Nordiazepam, Triazolam, Lorazepam, and Alprazolam in Blood This means that someone who took alprazolam might test negative on one brand of urine screen but positive on another, even at the same concentration. If a confirmatory test (like mass spectrometry) is ordered, it will specifically target alprazolam and its metabolites and is far less likely to miss a true positive. The takeaway: a negative result on a basic screen does not guarantee the drug is gone from your system. It may simply mean the screen was not sensitive enough for the amount remaining.
Withdrawal Timing Is Not the Same as Detection
People sometimes conflate how long a drug is detectable with how long withdrawal symptoms last. These are related but distinct timelines. Alprazolam is classified as a shorter-acting benzodiazepine, and withdrawal symptoms from short-acting benzodiazepines can begin within 24 hours of the last dose.13Brain Communications. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development That onset is much faster than for long-acting benzodiazepines like diazepam, where withdrawal may not start for three to seven days. This rapid onset is part of why alprazolam has a reputation for being harder to discontinue than some other drugs in its class.
For someone taking 0.5 mg on an as-needed basis, physical dependence and withdrawal are less of a concern than for daily users. But if you have been using even low doses regularly for several weeks, stopping abruptly can produce rebound anxiety, insomnia, and other symptoms that begin well before the drug has fully cleared your body. The drug might still be detectable in your urine while you are already experiencing withdrawal, because the brain’s adaptation to the drug’s presence begins to unravel at blood levels well above zero. This distinction matters for anyone trying to time a drug test around stopping use: feeling withdrawal symptoms does not mean the drug is undetectable.
Drug Interactions That Change the Timeline
Because alprazolam depends on CYP3A4 for metabolism, anything that inhibits or competes with that enzyme can slow elimination. Commonly prescribed medications that inhibit CYP3A4 include certain antifungals (like ketoconazole), some antibiotics (like clarithromycin), and several HIV protease inhibitors. Grapefruit juice is a well-known dietary inhibitor of CYP3A4 as well. If you are taking any of these alongside alprazolam, the drug’s effective half-life increases, meaning it stays in your system longer than the standard estimates would predict. The reverse is also true: drugs or substances that induce CYP3A4 activity, like certain antiepileptic medications, can speed up alprazolam clearance.
The practical implication is that “how long does 0.5 mg Xanax stay in your system” cannot be answered with a single number unless you account for what else is going on in your body. A healthy 25-year-old who takes a single 0.5 mg tablet with no other medications and no liver problems is looking at roughly two days for blood clearance and perhaps three to five days for urine. An older adult with liver disease who also takes a CYP3A4 inhibitor could be looking at double or triple those timelines. The 0.5 mg dose makes detection less likely to persist at the margins, but it does not make the drug disappear any faster in absolute pharmacokinetic terms.
Hair Testing and the Limits of a Single Low Dose
Hair analysis deserves a separate mention because it occupies a unique niche in drug testing. Unlike blood, urine, or saliva, hair does not reflect recent drug levels. Instead, it captures a historical record of drug exposure over weeks to months. Drugs are incorporated into hair through pathways in the hair bulb and the upper layers of the skin, and once embedded, they remain stable over time.6PubMed Central. Hair testing for investigating intake and use history of hypnotics in the forensic field Hair grows at roughly one centimeter per month, so a standard 3-centimeter sample provides a window spanning about 90 days.
The question of whether a single 0.5 mg dose will show up in hair is genuinely uncertain. Hair testing works best for detecting chronic or repeated use, where the drug has had many opportunities to deposit into the growing strand. A single low dose may deposit such a small quantity that it falls below the assay’s reporting threshold. Research on hair testing for hypnotics and benzodiazepines has focused primarily on people with documented histories of use, and the reliability of detecting a single low dose in an individual with no other exposure remains an open question. If you are facing a hair test and took one 0.5 mg tablet months ago, detection is possible but far from guaranteed.